Panakes Partners logo

Panakes Partners

Venture Capital

Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel.

Founded 2015 Italy Milan, Italy 1-10 employees Biotechnology, Finance +1

27

Total Investments

19

Portfolio Companies

-

Exits

3

Industries

General Information

Industries Biotechnology, Finance +1

Company Overview

Founded 2015
Employees 1-10
Location Italy Milan, Italy
Website panakes.it

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About Panakes Partners

Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel. Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We also have strong relationship with selected industrial partners to help companies to accelerate their development. Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion with which she healed the sick.

Recent Investments (27)

View All
Company Stage Amount Date
Series B •••••• May 2025
Series B •••••• Sep 2024
Series C •••••• Feb 2024
Series B •••••• Jan 2024
Seed Round •••••• Jan 2024
Portfolio company •••• ••••
Series C •••••• Nov 2023
Portfolio company •••• ••••
Series B •••••• Jul 2023
Portfolio company •••• ••••
Series A •••••• Jun 2023
Portfolio company •••• ••••
Series B •••••• Jun 2023
Portfolio company •••• ••••
Series A •••••• Apr 2023

See all 27 investments →

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes